Chengdu, China

Liwei Wu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liwei Wu. Retrieved from https://idiyas.com/inventor/liwei-wu-gg0l662s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liwei Wu - Innovator in Biodegradable Polymers

Introduction

Liwei Wu is a notable inventor based in Chengdu, China. He has made significant contributions to the field of biodegradable polymers, particularly in the development of novel amphiphilic peptides. His work focuses on enhancing the delivery of therapeutic agents and improving cell preservation techniques.

Latest Patents

Liwei Wu holds a patent for Poly(L-lysine isolphthalamide) (PLP) polymers with hydrophobic pendant chains. This patent relates to the provision of biodegradable amphiphilic peptides and peptide analogues that comprise hydrophobic chains. These innovations are aimed at the permeabilization of mammalian cells and the effective delivery of various agents, including therapeutic and imaging agents.

Career Highlights

Throughout his career, Liwei Wu has worked with various organizations, including Alphacells Biotechnologies Limited. His expertise in biodegradable materials has positioned him as a key figure in the biotechnology sector.

Collaborations

Liwei Wu has collaborated with notable colleagues such as Rongjun Chen and Siyuan Chen. Their combined efforts have contributed to advancements in the field of biopolymers and their applications.

Conclusion

Liwei Wu's innovative work in biodegradable polymers and his patent contributions highlight his role as a significant inventor in the biotechnology field. His research continues to pave the way for advancements in therapeutic delivery systems and cell preservation methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…